Dara signs agreement with WellCare for Soltamox formulary status

DARA BioSciences announced that the company signed a Medicare Part D Prescription Drug Program Reimbursement Agreement with Comprehensive Health Management, providing formulary status for the WellCare Group of companies for Soltamox oral solution. DARA holds exclusive U.S. marketing rights to Soltamox.